Orbimed Advisors LLC Vir Biotechnology, Inc. Transaction History
Orbimed Advisors LLC
- $4.24 Billion
- Q3 2024
A detailed history of Orbimed Advisors LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 3,573,000 shares of VIR stock, worth $28.6 Million. This represents 0.63% of its overall portfolio holdings.
Number of Shares
3,573,000
Previous 2,320,102
54.0%
Holding current value
$28.6 Million
Previous $20.6 Million
29.61%
% of portfolio
0.63%
Previous 0.5%
Shares
4 transactions
Others Institutions Holding VIR
# of Institutions
220Shares Held
87.4MCall Options Held
127KPut Options Held
1.19M-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$134 Million1.03% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$132 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$105 Million0.0% of portfolio
-
State Street Corp Boston, MA5.63MShares$45.1 Million0.0% of portfolio
-
Baillie Gifford & CO2.38MShares$19.1 Million0.01% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $1.06B
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...